Work

Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC)

Year: 2022

Type: article

Study design: Observational Study

Source: Urology

DOI: 10.1016/j.urology.2022.07.012

Authors: Michaela A. Dinan, Lauren E. Wilson, Melissa A. Greiner, Lisa P. Spees, Jessica E. Pritchard, Tian Zhang, Deborah Kaye, Daniel George, Charles D. Scales, Chris D. Baggett, Cary P. Gross, Michael S Leapman, Stephanie B. Wheeler

Institutions: Yale Cancer Center, Yale University, Duke University, Duke Medical Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Duke Cancer Institute

Language: English

Topic: Medication Adherence and Compliance

Subfield: Family Practice

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute, National Center for Chronic Disease Prevention and Health Promotion, National Center for Advancing Translational Sciences

Awards: G1044130170, G2238803135, G3161224617, Disparities in the Use of Oral Anticancer Agents in Kidney Cancer, G480705112, G5333917095, G5570217171, Yale Clinical and Translational Science Award

OpenAlex ID: W4286449073

FWCI: 1.644

Cites: 30

Cited by: 9

Related to: 10